Skip to main content
Premium Trial:

Request an Annual Quote

Quest Wraps Up Effort to Refocus on Dx Information Services; Lowers 2016 Revenue Guidance

NEW YORK (GenomeWeb) – Quest Diagnostics announced it has completed efforts to refocus its business on diagnostic information services following six divestitures that have yielded $1 billion in proceeds.

The latest divestiture was Quest's sale of Focus Diagnostics' products business to DiaSorin for $300 million in cash. That transaction completed last week.

Quest said it plans to use the money from this transaction to repurchase its common stock. The company has repurchased $2 billion in common stock since 2012.

"Completing our refocus effort by divesting the products business reaffirms our commitment to the diagnostic information services business," Quest CEO Steve Rusckowski said in a statement. "We have created shareholder value through the divestitures and our disciplined approach to capital deployment."

Additionally, Quest updated its annual revenue guidance to between $7.47 billion and $7.54 billion, which would be a 2 percent to 3 percent increase over its 2015 revenues of $7.32 billion. Previously, the company had projected 2016 revenues of between $7.52 billion and $7.59 billion.

Quest maintained its prior guidance for EPS between $5.02 and $5.17.

The Scan

Close Panel Vote on Califf Nomination

The New York Times reports there was a close committee vote to advance the nomination of Robert Califf to lead the US Food and Drug Administration to the full Senate.

Task Force Reports on Scientific Integrity

Nature News writes that that a new task force report recommends that the US establish a cross-agency scientific integrity council.

Across the Hall

Genetic testing, closed-circuit cameras, and more show how a traveler, without any contact, infected others at a New Zealand quarantine facility, CNN reports.

Science Paper Examines Influence of Chromatin Modifications on Obsessive-Compulsive Disorder

In Science this week: genes regulating chromatin modification may contribute to OCD risk.